APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study - Dufouil, C; Richard, F; Fiévet, N; Dartigues, J F; Ritchie, K; Tzourio, C; Amouyel, P; Alpérovitch, A (Neurology, 2005)
Keywords: Aged; Aged, 80 and over; Apolipoprotein E4; Apolipoproteins E - genetics; Causality; Cholesterol - blood; Clofibric Acid - therapeutic use; Cohort Studies; Cross-Sectional Studies; Dementia - blood; Dementia - epidemiology; Dementia - genetics; Female; France - epidemiology; Genetic Predisposition to Disease - genetics; Genetic Testing; Genotype; Health Surveys; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Hyperlipidemias - drug therapy; Hyperlipidemias - epidemiology; Hyperlipidemias - genetics; Hypolipidemic Agents - therapeutic use; Male; Prospective Studies; Surveys and Questionnaires; France